Paul G. Chaney - 01 Feb 2022 Form 4 Insider Report for KIORA PHARMACEUTICALS INC (KPRX)

Role
Director
Signature
/s/ Sarah Romano, Attorney-in-Fact*
Issuer symbol
KPRX
Transactions as of
01 Feb 2022
Transactions value $
$0
Form type
4
Filing time
03 Feb 2022, 18:05:09 UTC
Next filing
07 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KPRX Stock Option (right to buy) Award $0 +5K $0.00 5K 01 Feb 2022 Common Stock 5K $0.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2023.